PRSS30P

Across TCGA pan-cancer cohorts, PRSS30P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated PRSS30P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PRSS30P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PRSS30P expression acts as an unfavorable survival marker, although some lineages such as READ and BLCA show a favorable association.

KIRP, READ, and BLCA are the cancer types where PRSS30P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	III,IV	0.246	0.677	<.001	58	view →
READ	OS	Tertile	All	0.985	0.589	<.001	57	view →
BLCA	OS	Quartile	All	0.644	0.235	<.001	52	view →
LUAD	DFS	Median	IV	0.502	0.850	.003	42	view →
MESO	OS	Tertile	All	0.323	0.861	.001	30	view →
HNSC	DFS	Quartile	III,IV	0.622	0.476	.016	23	view →
UVM	DFS	Median	III,IV	0.314	0.877	.012	16	view →
THCA	DFS	Quartile	IV	1.000	0.666	.004	16	view →
THYM	DFS	Median	III,IV	1.000	0.508	.013	16	view →
UCEC	DFS	Quartile	IV	0.763	0.306	.030	12	view →
CESC	OS	Tertile	II,III,IV	0.800	0.460	.023	12	view →
SARC	DFS	Tertile	All	0.713	0.508	.017	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

PRSS30P–KIRP (DFS)

Open the KIRP breakdown →